Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 864 | 717 | 1,392 | 6,565 | 5,001 |
| Marketable Securities | 65 | 79 | 76 | 108 | N/A |
| Receivables | 1,155 | 760 | 856 | 426 | 303 |
| Inventories | N/A | N/A | N/A | 26 | 0 |
| Other current assets | 0 | 0 | 514 | 0 | 696 |
| TOTAL | $2,180 | $1,657 | $2,987 | $7,654 | $6,173 |
| Non-Current Assets | |||||
| PPE Net | 511 | 569 | 574 | 526 | 515 |
| Investments And Advances | 3,384 | 3,803 | 3,681 | 2,086 | 1,191 |
| Other Non-Current Assets | 1,465 | 1,756 | 2,338 | 3,433 | 3,728 |
| TOTAL | $5,360 | $6,128 | $6,592 | $6,044 | $5,434 |
| Total Assets | $7,540 | $7,785 | $9,580 | $13,698 | $11,607 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 773 | 174 | 360 | 393 | 311 |
| Accrued Expenses | 3,509 | 3,548 | 2,910 | 1,301 | 2,119 |
| Other current liabilities | 81 | 80 | 11 | 11 | 12 |
| TOTAL | $6,558 | $6,102 | $5,544 | $3,692 | $4,844 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 124 |
| Other Non-Current Liabilities | 615 | 922 | 689 | 332 | 4,778 |
| TOTAL | $259 | $429 | $800 | $1,135 | $4,100 |
| Total Liabilities | $6,816 | $6,531 | $6,343 | $4,828 | $8,945 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,778 | 10,560 | 3,308 | 3,031 | 2,442 |
| Common Shares | 14 | 8 | 3 | 29 | 24 |
| Retained earnings | -68,950 | -64,047 | -54,904 | -37,942 | -25,642 |
| Other shareholders' equity | 65 | 314 | -800 | -2,331 | -3,472 |
| TOTAL | $724 | $1,254 | $3,236 | $8,870 | $2,662 |
| Total Liabilities And Equity | $7,540 | $7,785 | $9,580 | $13,698 | $11,607 |